Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304149 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yichen Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China. Hauptthemen laut MEDLINE: Antimicrobial Cationic Peptides, Cell Proliferation, Down-Regulation, Glioblastoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Glioblastoma, the most aggressive form of brain cancer, poses a significant global health challenge with a considerable mortality rate. With the predicted increase in glioblastoma incidence, there is an urgent need for more effective treatment strategies. In this study, we explore the potential of caerin 1.1 and 1.9, host defence peptides derived from an Australian tree frog, in inhibiting glioblastoma U87 and U118 cell growth. Our findings demonstrate the inhibitory impact of caerin 1.1 and 1.9 on cell growth through CCK8 assays. Additionally, these peptides effectively curtail the migration of glioblastoma cells in a cell scratch assay, exhibiting varying inhibitory effects among different cell lines. Notably, the peptides hinder the G 0 /S phase replication in both U87 and U118 cells, pointing to their impact on the cell cycle. Furthermore, caerin 1.1 and 1.9 show the ability to enter the cytoplasm of glioblastoma cells, influencing the morphology of mitochondria. Proteomics experiments reveal intriguing insights, with a decrease in CHI3L1 expression and an increase in PZP and JUNB expression after peptide treatment. These proteins play roles in cell energy metabolism and inflammatory response, suggesting a multifaceted impact on glioblastoma cells. In conclusion, our study underscores the substantial anticancer potential of caerin 1.1 and 1.9 against glioblastoma cells. These findings propose the peptides as promising candidates for further exploration in the realm of glioblastoma management, offering new avenues for developing effective treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China.
- Zhong'ao Biomedical Technology (Guangdong) Co., Ltd, Zhongshan, Guangdong, China.
- Cancer Research Institute, First People's Hospital of Foshan, Foshan, Guangdong, China.
- Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD, Australia.
- School of Science, Technology and Engineering, University of the Sunshine Coast, Maroochydore BC, QLD, Australia.
- Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, Guangzhou, China.
ORCID-Profile: Tianfang Wang
Förderung
- NIA NIH HHS
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- Deng Feng project of Foshan First People’s Hospital
- Foshan Municipal Government
- Guangdong Provincial Department of Science and Technology
Zitieren
APA
Wang, Y., Zhong, F., Xiao, F., Li, J., Liu, X., Ni, G., Wang, T., & Zhang, W. (2024). Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1. PLOS ONE. https://doi.org/10.1371/journal.pone.0304149
Vancouver
Wang Y, Zhong F, Xiao F, Li J, Liu X, Ni G, et al. Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1. PLOS ONE. 2024. doi:10.1371/journal.pone.0304149
BibTeX
@article{Wang2024,
author = {Wang, Yichen and Zhong, Furong and Xiao, Fengyun and Li, Junjie and Liu, Xiaosong and Ni, Guoying and Wang, Tianfang and Zhang, Wei},
title = {Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304149}
}
EUVIMED